Lidén, Mats http://orcid.org/0000-0002-1346-1450
Spahr, Antoine
Hjelmgren, Ola
Bendazzoli, Simone
Sundh, Josefin
Sköld, Magnus
Bergström, Göran
Wang, Chunliang
Thunberg, Per
Funding for this research was provided by:
Nyckelfonden, Örebro (OLL-881491)
Analytic Imaging Diagnostics Arena, Linköping, Sweden (2104_Liden)
Region Örebro län (OLL-959996)
Örebro University
Article History
Received: 20 January 2023
Revised: 18 April 2023
Accepted: 29 May 2023
First Online: 8 August 2023
Declarations
:
: The scientific guarantor of this publication is Mats Lidén, MD, Assoc Prof.
: No industry support was provided for the project, and the authors have no conflicts of interest to declare related to the project. Not related to this project, MS has received consultancies from Roche, Boehringer, Ingelheim, Novartis, Pfizer, AstraZeneca, GlaxoSmithKline, and Chiesi.
: One of the authors (ML) has significant statistical expertise.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: Concerning machine learning CT emphysema assessment, the validation cohort has not been previously reported. Related to the present work, the subjects in the development cohort have previously been reported by Vikgren et al [CitationRef removed] and Lidén et al [CitationRef removed].
: • Prospective inclusion• Cross-sectional• Single inclusion site